LQDA
LQDA
NASDAQ · Pharmaceuticals

Liquidia Corp

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$36.61
+1.41 (+4.01%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 13 87%
Hold 1 7%
Sell 1 7%
Price Target
Analyst Price Target +17.9% upside
Low Target $30.71
Average Target $43.17
High Target $51.56
Current Price $36.61
Current
$36.61
Target
$43.17
$30.71 $43.17 avg $51.56
Scenario Analysis
Bear Case
$30.71
-16.1%
Low target
Base Case
$43.17
+17.9%
Avg target
Bull Case
$51.56
+40.8%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$46.67
-21.6% from high
52-Week Low
$11.26
+225.1% from low
50-Day SMA
$37.31
-1.9% vs SMA
200-Day SMA
$25.48
+43.7% vs SMA
RSI (14)
31.7
Neutral
Target vs 52W High
$43.17
-7.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +809.8%